US Senators have asked the drug maker Pfizer and five other health companies to detail their agreements to block prescriptions of generic versions of the cholesterol drug Lipitor and sell only the Pfizer brand-name version. Doing this is an effect from the ending on the Lipitor patent and now the senators wish to have the government regulate the drug to promote the general welfare. Although by selling one generic brand of drugs, it would make a less competitive market which would stimulate profit and be more available to public access. However, it is feared that this can cause a monopoly on the lipitor market and cause Medicare, and other healthcare programs to reply on Pfizer corporation where they must pay their prices.
Is it a mistake to allow government regulation over such a drug? do the drugs pose as a danger to society?
No comments:
Post a Comment